West Pharmaceutical Services, Inc. (NYSE:WST) will issue its quarterly earnings data before the market opens on Wednesday, October 25th. Analysts expect the company to announce earnings of $0.61 per share for the quarter. West Pharmaceutical Services has set its FY17 guidance at $2.66-2.73 EPS.

West Pharmaceutical Services (NYSE:WST) last released its quarterly earnings data on Thursday, July 27th. The medical instruments supplier reported $0.66 earnings per share for the quarter, beating the consensus estimate of $0.65 by $0.01. The business had revenue of $397.60 million for the quarter, compared to analyst estimates of $406.00 million. West Pharmaceutical Services had a return on equity of 14.02% and a net margin of 11.42%. The company’s revenue was up 2.5% compared to the same quarter last year. During the same period in the previous year, the company posted $0.59 EPS. On average, analysts expect West Pharmaceutical Services to post $2.67 EPS for the current fiscal year and $2.91 EPS for the next fiscal year.

West Pharmaceutical Services, Inc. (NYSE:WST) opened at 93.00 on Wednesday. West Pharmaceutical Services, Inc. has a 1-year low of $70.17 and a 1-year high of $99.91. The stock has a 50 day moving average price of $92.70 and a 200 day moving average price of $91.36. The firm has a market capitalization of $6.88 billion, a price-to-earnings ratio of 39.91 and a beta of 1.11.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, November 1st. Shareholders of record on Wednesday, October 18th will be paid a $0.14 dividend. The ex-dividend date is Tuesday, October 17th. This represents a $0.56 dividend on an annualized basis and a yield of 0.60%. This is an increase from West Pharmaceutical Services’s previous quarterly dividend of $0.13. West Pharmaceutical Services’s payout ratio is 22.22%.

COPYRIGHT VIOLATION NOTICE: This report was originally published by American Banking News and is the sole property of of American Banking News. If you are reading this report on another website, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright legislation. The legal version of this report can be read at https://www.americanbankingnews.com/2017/10/18/west-pharmaceutical-services-inc-wst-set-to-announce-quarterly-earnings-on-wednesday.html.

A number of research analysts have commented on WST shares. Jefferies Group LLC upgraded West Pharmaceutical Services from a “hold” rating to a “buy” rating and boosted their target price for the company from $96.00 to $115.00 in a research note on Friday, September 15th. BidaskClub downgraded West Pharmaceutical Services from a “buy” rating to a “hold” rating in a research note on Wednesday, July 5th. Zacks Investment Research downgraded West Pharmaceutical Services from a “buy” rating to a “hold” rating in a research note on Tuesday, July 4th. Bank of America Corporation downgraded West Pharmaceutical Services from a “buy” rating to a “neutral” rating and set a $98.00 price target for the company. in a research note on Tuesday. Finally, Stephens started coverage on West Pharmaceutical Services in a research note on Tuesday, October 3rd. They set an “equal weight” rating and a $99.00 price target for the company. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $104.00.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.

Earnings History for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services Inc. and related companies with MarketBeat.com's FREE daily email newsletter.